Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-07 Latour Wouter Director Option exercise +100,000 $1.70 $170K 100,000
2021-05-07 Latour Wouter Director Sale −100,000 $7.13 $713K 0
2021-05-07 Latour Wouter Director Option exercise · Stock Option (right to buy) −100,000 700,000
2021-05-06 Latour Wouter Director Option exercise +100,000 $1.70 $170K 100,000
2021-05-06 Latour Wouter Director Sale −100,000 $6.54 $654K 0
2021-05-06 Latour Wouter Director Option exercise · Stock Option (right to buy) −100,000 800,000
2021-03-04 Latour Wouter Director Option exercise +150,000 $0.77 $116K 150,000
2021-03-04 Latour Wouter Director Sale −150,000 $6.04 $906K 0
2021-03-04 Latour Wouter Director Option exercise · Stock Option (right to buy) −150,000 213,261
2020-11-23 Latour Wouter Director Sale −333,334 $6.32 $2.1M 0
2020-08-12 Latour Wouter Director Option exercise +166,667 $0.30 $50K 333,334
2020-08-12 Latour Wouter Director Option exercise · Common Stock Purchase Warrant −166,667 $0.30 $50K 0
2020-06-08 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +900,000 900,000
2019-09-30 Latour Wouter President and Chief Executive Purchase +166,667 $0.30 $50K 166,667
2019-09-30 Latour Wouter President and Chief Executive Purchase · Common Stock Purchase Warrant +166,667 $0.30 $50K 166,667
2019-05-12 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +363,261 363,261
2018-05-25 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +110,700 110,700
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +6,536 6,536
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +9,442 9,442
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +13,256 13,256

Page 1 of 2 · 24 trades